ED USE OF RAPID LACTATE TO EVALUATE PATIENTS WITH ACUTE CHEST PAIN

Citation
Nj. Schmiechen et al., ED USE OF RAPID LACTATE TO EVALUATE PATIENTS WITH ACUTE CHEST PAIN, Annals of emergency medicine, 30(5), 1997, pp. 571-577
Citations number
29
Categorie Soggetti
Emergency Medicine & Critical Care
ISSN journal
01960644
Volume
30
Issue
5
Year of publication
1997
Pages
571 - 577
Database
ISI
SICI code
0196-0644(1997)30:5<571:EUORLT>2.0.ZU;2-4
Abstract
Study objective: To test the hypothesis that ED arrival venous lactate levels can be used to diagnose acute myocardial infarction (AMI) and to identify patients with critical illness in the triage of ED patient s presenting with chest pain. Methods: This was a prospective, double- blind, clinical study in an urban, academic ED. We enrolled a convenie nce sample of adult patients who had chest pain or cardiac symptoms su ggesting AMI that began within 24 hours of presentation. Patients unde rwent standard medical management for their chest pain. Venous lactate samples were analyzed in the ED on whole blood. An abnormal lactate l evel of 1.5 mmol/l or higher at the time of arrival was prospectively defined as indicating the presence of acute cardiac disease. ECG findi ngs, levels of creatine phosphokinase (CK) and CK-MB, hospital stay da ta, and diagnosis of AMI by the cardiology admitting team were recorde d. Results: Of the 129 patients included in the study, 73 had an initi al lactate level of 1.5 mmol/L or higher. The mean lactate level (+/-S D) for all patients was 1.8+/-1.2 mmol/L. A total of 28 patients (21%) were diagnosed with AMI and had a mean lactate level of 2.2+/-.7 mmol /L, compared with 1.7+/-1.3 mmol/l in those patients who were not diag nosed with AMI (P<.03). The sensitivity of this lactate level in diagn osing AMI was 96% (95% confidence interval [CI], 89% to 100%), and the specificity was 55% (95% CI, 45% to 64%). The negative predictive val ue of blood lactate was 98% (95% CI, 95% to 100%). Lactate was elevate d independent of the duration of chest pain symptoms, with a median ti me from onset to sampling of 3 hours. Lactate was elevated in patients who either died or required longer than 48 hours of ICU care, compare d with survivors not requiring ICU care (4.5+/-4.3 mmol/L versus 1.4+/ -.6 mmol/l, respectively; P<.01). Conclusion: The blood lactate concen tration obtained on ED arrival identifies those chest pain patients wi th critical cardiac illness leg, AMI, severe congestive heart failure [CHF], decompensated arrhythmias). A normal blood lactate result has a high negative predictive value for AMI. An elevated lactate level use d in conjunction with ECG and history distinguishes patients with sign ificant myocardium at risk who are likely to benefit from more urgent attention and interventions by the attending physician. Additionally, hyperlactatemia clearly correlates with mortality and the need for ICU management in the acute cardiac patient presenting to the ED.